Skip to main content

Moderna to build vaccine production facility in Montreal area

Federal Innovation Minister Francois-Philippe Champagne, left, and Stephane Bancel, chief executive of Moderna Therapeutics, visit a COVID-19 vaccination clinic, on August 10, 2021 in Montreal. File photo by The Canadian Press/Ryan Remiorz

Support strong Canadian climate journalism for 2025

Help us raise $150,000 by December 31. Can we count on your support?
Goal: $150k
$32k

American vaccine maker Moderna is to announce today it plans to build its promised Canadian production facility in Montreal.

Prime Minister Justin Trudeau, Moderna CEO Stéphane Bancel, and Quebec Premier François Legault are scheduled to attend a Friday morning health care announcement in the city.

Montreal Mayor Valérie Plante confirmed the news Thursday, but Moderna would only say that it was still finalizing an agreement to construct a biomanufacturing facility in Canada.

Moderna signed an initial agreement with the federal government last August to bring such a factory to Canada, with the details on where to be worked out.

At the time Bancel said he believed it would allow Canada to be ready for the next virus.

#Moderna vaccine production facility to be built in the #Montreal area. #Covid19 #biomanufacturing #Covid19

The Canadian agreement includes both production and vaccine research components with the building to be completed by 2024.

Canada's biomanufacturing industry has declined but what remains is centred in Quebec and the Greater Toronto Area. Both were in the running for this plant.

Moderna's COVID-19 vaccine is its first authorized product but it now has more than two dozen others in various stages of research, including mRNA vaccines for influenza and respiratory syncytial virus, or RSV.

This report by The Canadian Press was first published April 29, 2022

Comments